Today: 20 May 2026
Browse Category

Earnings Reports 29 October 2025 - 30 October 2025

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb reported Q3 adjusted EPS of $1.63 on $12.2 billion revenue, beating estimates, and raised its 2025 outlook. Shares rebounded 3–4% after hitting a 52-week low, with dividend yield now near 5.5%. New drugs like Opdivo and Eliquis outperformed, offsetting a sharp Revlimid decline. The company acquired Orbital Therapeutics and launched schizophrenia drug Cobenfy, posting $62 million in early sales.
Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria reported Q3 net revenue down 3% to $6.07 billion and adjusted EPS of $1.45, matching estimates. Shares fell nearly 4% pre-market, trading about 10% below recent highs. The company doubled its buyback program to $2 billion and raised its 2025 earnings outlook floor. Cigarette and oral tobacco sales declined, while NJOY e-cigarette sales remain halted due to a patent dispute.
Comcast Shocker: Cord-Cutting Slows, Wireless Soars in Q3 Earnings

Comcast Shocker: Cord-Cutting Slows, Wireless Soars in Q3 Earnings

Comcast Q3 net income fell 8.2% to $3.33 billion, but adjusted EPS of $1.12 and revenue of $31.2 billion beat forecasts. Broadband and pay-TV subscriber losses slowed, while Xfinity Mobile added a record 414,000 lines. Peacock’s EBITDA loss narrowed to $217 million, and theme park revenue rose nearly 19%. Free cash flow jumped 45% to $4.9 billion; shares rose about 2% pre-market.
Mastercard Stock Rockets on Q3 Earnings Beat and $2B Crypto Play – What Investors Should Know

Mastercard Stock Rockets on Q3 Earnings Beat and $2B Crypto Play – What Investors Should Know

Mastercard reported Q3 2025 revenue of $8.60 billion, up 17% year-over-year, with net profit rising 20% to $3.96 billion. Shares traded near $570 in October, up about 8% year-to-date and close to their 52-week high. The company announced support for major US dollar stablecoins and is in late-stage talks to acquire crypto firm ZeroHash for up to $2 billion. About 80% of analysts rate the stock a buy.
Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen shares fell about 2.6% after hours Oct. 30 following Q3 results that beat estimates, with revenue at $2.53 billion and adjusted EPS of $4.81. The company cut 2025 non-GAAP EPS guidance to $14.50–$15.00, citing a $1.25 per-share R&D charge. Leqembi sales reached $121 million, up 80% year-over-year. Biogen licensed Vanqua Bio’s inflammation drug for up to $1.06 billion.
Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna shares closed at $299.12 on Oct 29, down 3% for the week, before rising to $303 in Oct 30 premarket trading. The company reported Q3 revenue of $69.7 billion and net income of $1.87 billion, beating forecasts and reaffirming its full-year outlook. Cigna launched a new pharmacy benefit model and Evernorth invested $3.5 billion in Shields Health. Analyst consensus remains bullish with a $370–$377 price target.
Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Merck (MRK) Stock Dips on Earnings Beat — Will Pipeline Boost Spur a Rally?

Merck shares fell about 2% after hours Oct. 30 despite Q3 revenue of $17.28 billion and $2.58 adjusted EPS, both above estimates. Keytruda sales rose 10% to $8.1 billion. The company narrowed its 2025 sales outlook and raised profit guidance. Recent milestones include FDA approval of subcutaneous Keytruda and the $10 billion acquisition of Verona Pharma.
Inside Samsung: How the Tech Giant is Dominating Every Industry It Touches

Samsung Stock Soars on AI Chip Boom – Q3 Earnings Crush Estimates

Samsung Electronics shares jumped 3.6% to ₩104,100 on October 30, hitting a 52-week high after Q3 revenue reached ₩86.1 trillion and operating profit rose 32% to ₩12.2 trillion, fueled by record AI chip sales. The company plans major expansion of high-bandwidth memory production for AI servers. Samsung also launched its first Galaxy XR headset and announced a DRAM supply deal with OpenAI.
Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown

Alphabet (GOOG) Hits Record High on Q3 Earnings Beat, AI Boom Fueling Rally

Alphabet shares jumped 6% to a record high near $270 on Oct. 30 after third-quarter earnings and revenue beat forecasts. Google’s ad revenue rose 12.6% to $74.2 billion, and cloud sales surged 34% to $15.16 billion. The company raised 2025 capital spending to as much as $93 billion for AI and cloud expansion. Wall Street remains bullish, with most analysts rating the stock a “Buy.”
Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle Stock Craters After Tepid Q3 Earnings – What’s Next for CMG?

Chipotle shares plunged 18% pre-market Oct. 30 after management cut its 2025 same-store sales forecast to a low-single-digit decline, citing persistent macroeconomic pressures. Q3 revenue rose 7.5% to $3.0 billion, but same-store sales grew just 0.3% as customer traffic fell for the third straight quarter. Chipotle opened 84 new restaurants and repurchased $686.5 million in stock. The stock is down 34% year-to-date.
Fiserv Earnings Miss Expectations, Shares Slide – What’s Next for the Fintech Giant?

Shock Selloff: Fiserv (FI) Stock Plunges 40% After ‘Shockingly Bad’ Q3, Major Shakeup Unveiled

Fiserv shares plunged about 42% to a 52-week low near $66 on Oct. 29, 2025, after missing Q3 estimates and slashing 2025 guidance. Adjusted EPS came in at $2.04 on $4.92 billion revenue, both well below forecasts. CEO Mike Lyons announced a turnaround plan and major leadership changes. The company will move its listing from NYSE to Nasdaq on Nov. 11.
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock on Fire: GLP-1 Bonanza, Big Earnings & AI Pivot Drive Rally

Eli Lilly reported Q3 2025 revenue of $17.60 billion, up 54% year-over-year, and raised full-year EPS guidance to $23.00–23.70. Shares closed at $813.53 on Oct. 29, down 2% over the week after hitting highs above $850 earlier in the month. The FDA approved Inluriyo for metastatic breast cancer, and the EU cleared Kisunla for early Alzheimer’s. Wall Street’s average 12-month price target stands near $939.
ServiceNow (NOW) Stock Soars on AI-Driven Earnings and 5-for-1 Stock Split

ServiceNow (NOW) Stock Soars on AI-Driven Earnings and 5-for-1 Stock Split

ServiceNow shares closed at $911.70 on Oct. 29, down 2.8%, but jumped about 4% in after-hours trading after strong Q3 results and a five-for-one stock split announcement. Subscription revenue rose 21.5% to $3.30 billion, beating forecasts. The company raised its full-year sales outlook. Analysts maintain a “Strong Buy” rating, with average targets near $1,117.
MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

MercadoLibre Stock Dips After Q3 Earnings Miss – Can Brazil Deal Ignite a Rally?

MercadoLibre closed at $2,290 on Oct. 28, up 20% year-to-date, with a market cap near $116 billion. Q3 revenue rose 39% to $7.41 billion, beating estimates, but net income of $421 million missed forecasts. The company announced a deal to sell Casas Bahia appliances and entered Brazil’s online pharmacy market. Shares dipped 1.6% after earnings; most analysts remain bullish with a $2,800 target.
ProPetro (PUMP) Soars on Data Center Power Deal and Q3 Earnings Beat – What’s Driving the Rally?

ProPetro (PUMP) Soars on Data Center Power Deal and Q3 Earnings Beat – What’s Driving the Rally?

ProPetro shares surged nearly 14% after its PROPWR unit secured a long-term contract to supply 60 megawatts to a major data center. Q3 revenue reached about $294 million, down 18.6% year-over-year but beating estimates by 14%. The company narrowed its quarterly loss to $2 million and reported $25 million in free cash flow from fracking. PROPWR’s total contracted capacity now exceeds 150 MW.
Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?

Meta’s Stock Plunges 6% After Shocking Q3 Earnings: AI Costs and $15B Tax Bombshell

Meta posted Q3 2025 revenue of $51.24 billion, up 26% and above forecasts, driven by strong ad sales and 3.54 billion daily users. GAAP EPS fell to $1.05 after a $15.93 billion tax charge, far below analyst estimates, but adjusted EPS was $7.25. Shares closed flat at $752 before dropping 6% after hours. Meta raised 2025 capex guidance to $70–72 billion for AI data centers.
Flowserve Stock Skyrockets 30% After Earnings Triple and Guidance Hike – Is More Upside Ahead?

Flowserve Stock Skyrockets 30% After Earnings Triple and Guidance Hike – Is More Upside Ahead?

Flowserve shares jumped nearly 30% to about $68.50 on October 29, 2025, after Q3 adjusted earnings of $0.90 per share beat forecasts and profit tripled year-over-year. The company raised full-year earnings guidance and offloaded legacy asbestos liabilities, while a $266 million breakup fee from a failed merger boosted cash. Market cap reached around $9 billion.
29 October 2025
1 239 240 241 242 243 250

Stock Market Today

  • Live Cattle and Feeder Cattle Futures Rally on Tuesday
    May 20, 2026, 9:00 AM EDT. Live cattle futures rose by 10 to 120 cents on Tuesday, following limited cash trade after last week's $260-$265 sales. Feeder cattle futures surged by $4.35 to $4.80, with May contracts up 77 cents. The CME Feeder Cattle Index dropped 2.46 points to 367.63 on May 15. Wholesale boxed beef prices increased, with Choice boxes climbing $3.61 to $395.75 and Select up $3.35 to $393.58. USDA reported cattle slaughter at 110,000 head Tuesday, marginally higher week-on-week but down 23,103 from last year. Additionally, the USDA APHIS reported nearly 1,889 active New World Screwworm cases in Mexico, some near the U.S. border, posing potential livestock health concerns.

Latest articles

NextNRG Shares Double as Record April Sales Drive Gains

NextNRG Shares Double as Record April Sales Drive Gains

20 May 2026
NextNRG Inc. shares fell to $0.73 in premarket trading Wednesday after doubling Tuesday, as investors reacted to record April revenue of $9.4 million and a 64% jump in gross profit. The company reported just $208,048 in cash at March 31 and is seeking new capital. Net loss for the first quarter widened to $10.8 million despite higher sales. Results are preliminary and unaudited.
GCL Global up after ADATA invests $10M; Nasdaq $1 rule still ahead

GCL Global up after ADATA invests $10M; Nasdaq $1 rule still ahead

20 May 2026
GCL Global Holdings said ADATA invested another $10 million in its 4Divinity unit, bringing total disclosed ADATA commitments since December to $23 million. GCL shares traded at about 80 cents in U.S. premarket, up from Tuesday’s 43-cent close, but still below Nasdaq’s $1 minimum bid rule, which it must meet by Sept. 14.
Analog Devices heads into AI test after record quarter, $1.5 billion deal

Analog Devices heads into AI test after record quarter, $1.5 billion deal

20 May 2026
Analog Devices reported fiscal second-quarter revenue up 37% to $3.62 billion, beating estimates, with adjusted EPS at $3.09. The company forecast third-quarter revenue of $3.9 billion, above Wall Street expectations, and announced a $1.5 billion cash deal to acquire Empower Semiconductor to expand in AI power delivery.
Go toTop